Browse the detailed record of transactions filed by Liang Peng, 管理人员. Officer active across 1 company, notably Clover Biopharmaceuticals, Ltd. - B. Aggregated, 18 reports have been published. History available since 13 March 2026. The latest transaction was disclosed on 9 September 2026 (Sale). Regulator: HKEX. All data is free.
Companies and markets linked to Liang Peng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Liang Peng is a Dirigeant and Director at Clover Biopharmaceuticals, Ltd. - B (XHKG). He has 17 filings in total, and across the sampled recent filings from 2026-03-19 to 2026-07-21, the reported activity is only sales, totaling EUR 622892.